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LRINEC – AN OBJECTIVE SCORING SYSTEM AS A TOOL FOR 
EARLY DIAGNOSIS OF NECROTIZING FASCIITIS 
BACKGROUND 
Skin and/or subcutaneous tissue infections are highly diverse with regard 
to etiology, predisposing organisms, incidence, clinical features, severity and 
complications.The spectrum of deep soft tissue infections ranges from localized 
lesions to rapidly spreading, tissue destructive infections such as necrotizing 
fasciitis and myonecrosis. Necrotizing soft tissue infections are often fatal, 
characterized by extensive necrosis of thesubcutaneous tissues and fascia.The 
reported mortality of 30-40% reflects the inadequacy of early recognition of 
Necrotizing soft tissue infections. This study emphasizes on the search for a tool 
that reliably and rapidly identifies patients with NF and helps to decide for 
earlier effective therapy to modify clinical outcome. 
AIM OF THE STUDY 
To Validate the LRINEC (Laboratory Risk Indicator for Necrotizing 
Fasciitis) score as a tool for early distinguishing of Necrotizing Fasciitis from 
other infections of the soft tissues. 
METHODS 
Sixty of patients with soft tissue infections were evaluated prospectively 
on the basis of Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC). 
Based on their LRINEC score, the patients were categorised as Low, 
Intermediate and High Risk for the onset of Necrotizing fasciitis. Patients in 
each category were appropriately managed. All variables in terms of 
progression of the disease, associated co-morbidity, onset of necrotizing 
fasciitis, number of debridement, outcome of the disease in each category were 
documented and statistically analysed to evaluate the significance of LRINEC 
score in predicting the onset of Necrotizing fasciitis and its clinical outcomes. 
RESULTS 
A total of 60 patients with soft tissue infections were prospectively 
evaluated in this study and categorised on the basis of LRINEC score – 45 
patients in Low risk category, 7 in Intermediate risk and 8 patients in High risk 
group.This study included forty two males (70%) and eighteen females (30%). 
Diabetes mellitus was the most common co-morbidity (23 cases). Tissue 
diagnosis was positive for necrotizing fasciitis in 7 cases of low risk, 1 case in 
intermediate risk and 3 cases in high risk group. Required mean number of 
debridement is 1.6 times . In terms of outcome, all cases ( including positive 
tissue diagnosis cases) in low risk and intermediate risk groups and 2 cases in 
high risk group were improved with surgical dedridement/fasciotomy. 
2 cases required amputation and 3 cases were dead. There is no 
statistically significant difference between the mean age between the groups of 
severity. The cut off of LRINEC ≥ 6 has better sensitivity and specificity in 
identifying the risk of the patient. The p-value (0.001) reveals that there is an 
association between Diabetes Mellitus and the severity of risk. The p-
value(0.08)  for the comparison of mean hospital days among the group of 
severity indicates that there is no difference between the mean of hospital stay.  
CONCLUSION 
LRINEC scoring system has a better positive predictive value in 
identifying the onset of necrotizing fasciitis and risk strategizing of the patients 
with severe soft tissue infections.There is a statistically significant association 
between Diabetic Mellitus and the severity of risk. The significance of LRINEC 
score in predicting the clinical outcome of the disease could not be outlined 
because of limited population included in this study. Further studies are needed 
to determine whether additional interventions targeted to the high mortality risk 
group can lead to improved outcomes. 
KEY WORDS 
NF  - Necrotizing Fasciitis  
LRINEC - Laboratory Risk Indicator for Necrotizing Fasciitis  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
______________________________________________________________________________________________________________________ 
 
  
Skin and/or subcutaneous tissue infections are highly diverse with regard 
to etiology, predisposing organisms, incidence, clinical features, severity and 
complications. 
They may occur as single or recurrent episodes. The spectrum of deep 
soft tissue infections ranges from localized bacterial, viral and parasitic lesions 
to rapidly spreading, tissue destructive infections such as necrotizing fasciitis 
and myonecrosis. 
When a patient presents with soft tissue infection, the clinician faces the 
challenge of establishing a specific diagnosis and prescribing definitive 
treatment. Even the experienced clinician may have difficulty distinguishing 
between the different forms of deep soft tissue infection during the early stages. 
Necrotizing soft tissue infections are often fatal, characterized by 
extensive necrosis of the subcutaneous tissues and fascia. Perhaps it is the most 
severe form of soft tissue infection potentially limb and life threatening. These 
infections  often are  mistaken for cellulitis or innocent wound infections and 
hence, diagnostic delay. Inspite of advances in antibiotic therapy and intensive 
care, the mortality of necrotizing soft tissue infections is still high. The reported 
mortality of 30-40% reflects the inadequacy of early recognition of Necrotizing 
soft tissue infections.  
  
This study emphasizes on the search for a tool that reliably and rapidly 
identifies patients with NF and helps to decide for earlier effective therapy to 
modify clinical outcome. 
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AIM OF THE STUDY: 
 To Validate the LRINEC (Laboratory Risk Indicator for Necrotizing 
Fasciitis) score as a tool for early distinguishing of Necrotizing Fasciitis from 
other infections of the soft tissues. 
 
OBJECTIVES: 
1. To determine whether laboratory risk indicators based on LRINEC score 
among patients with severe soft tissue infectionswould predict the onset 
and presence of an early stage of necrotizing fasciitis. 
2. To evaluate whether risk categorization using LRINEC score is 
appropriate. 
3. To identify the significance of LRINEC score in predicting the clinical 
outcomes. 
4. To interpret the accuracy of score in the presence of co-morbid conditions 
 
 
 
 
 
 
 
 
 
 
  
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Review of Literature 
______________________________________________________________________________________________________________________ 
 
  
 
EPIDEMIOLOGY 
Necrotizing fasciitis (NF) is a well-defined, persistent, and pervasive 
disease in which the fascia is the primary site of infection. Necrotizing fasciitis 
has been described in medical texts since 1871
1
 and in the surgical literature 
since 1924
2
. 
Although the exact incidence of these infections in the general population 
is unknown, they are among the most common infections occurring in all age 
groups. Some are age-related, for example impetigo commonly in children and 
erysipelas common in older adults. 
Until the mid-of 20th century, wartime injuries were commonly 
complicated by gas gangrene caused by Clostridium spp. Those were the time 
of civil war in USA, when nearly 50% of soldiers who sustained gunshot 
injuries developed infection and most of them developed gas gangrene. 
Clostridial gangrene is typically a sporadic infection but during the Civil War 
apparent epidemics of 'hospital gangrene' were described. Contributing factors 
included severe trauma, grossly contaminated wounds, crowded and dirty 
conditions, application of soiled dressings (often recycled from patients who 
had just died of infection) and primitive surgical techniques for debridement 
and fixation of open fractures.  
  
Group A streptococci undoubtedly caused some of these infections but 
other major bacterial pathogens, including Clostridium perfringens, Gram-
negative bacteria and mixed aerobic-anaerobic bacteria, also contributed. 
Gas gangrene was also common during the First World War, particularly 
in the European theatre, where the soil was rich and well fertilized with animal 
faeces containing large numbers of vegetative spores of clostridia. In contrast, in 
North Africa, cases of gangrene following gunshot wounds were far less 
common, presumably because the desert sand contained few Clostridial spores
3
. 
In modern warfare, gas gangrene has become uncommon because 
wounded soldiers are evacuated rapidly to well-equipped hospitals for surgical 
intervention, arterial reconstruction and antibiotic treatment, all of which have 
greatly reduced the prevalence of this feared disease. 
In modern times, these serious deep soft tissue infections have become 
less common. Sporadic cases in the general population most often occur as 
occasional complications of penetrating trauma, compound fractures or septic 
abortions. For the first time in history, spontaneous gas gangrene caused by 
Clostridium septicum may be more common than trauma-associated gas 
gangrene caused by C. histolyticum, C. perfringens or other Clostridium spp.   
Recently, severe soft tissue infections due to C. sordellii, C. perfringens, 
and C. novyi have been described among intradermal ('skin popping') and 
intravenous drug users.
4, 5 
  
Necrotizing fasciitis, a life-threatening soft tissue infection, can occur in 
association with gas gangrene as a part of generalized tissue necrosis or as a 
separate clinical entity. 
PATHOGENESIS 
The skin is an organ that reacts to infectious, noxious, external and 
internal stimuli in a limited number of ways. The rich plexus of capillaries 
beneath the dermal papillae provides nutrition to the stratum germinativum and 
the dermatocytes, which are bound together by tight junctions and form the 
barrier to microbial invasion. Once microbes have penetrated this barrier 
through a hair follicle, cut or bite, the dermal plexus of capillaries delivers the 
components of the host's defence — oxygen, complement, immunoglobulins, 
macrophages, lymphocytes and granulocytes — to the site of infection. 
Release of proinflammatory cytokines such as IL-1, IL-6 and tumor 
necrosis factor- alpha, results in an augmentation of the immune functions 
described above. These cytokines induce fever, prime neutrophils, and increase 
antibody production and the synthesis of acute phase reactants, such as C-
reactive protein. Cytokine driven stimulation of endothelial cells also results in 
the generation of nitric oxide and prostaglandins, both of which cause 
vasodilation. The net physiologic effect is greater blood flow to the tissue.  
 
 
  
These processes result in the cardinal features of inflammation (Fig.1): 
¦ Erythema, 
¦ Swelling, 
¦ Heat and 
¦ Tenderness or pain. 
 
Fig.1 Signs of Inflammation 
If tissue perfusion is moderately attenuated, tissues may remain viable, but 
the threshold for progression of infection may be lowered.  
Predisposing conditions in this category include: 
• peripheral vascular disease affecting large arteries, 
• diabetes mellitus causing microvascular disease, and 
• Chronic venous stasis causing post capillary obstruction. 
  
Most fungi and bacteria multiply in the viable tissue, but the spread of 
infection is limited by the fibrous attachments in between subcutaneous tissues 
and fascia. The natural lack of fibrous attachments facilitates wide spread 
infection especially in the trunk or extremities. The superficial fascia being the 
primary site of such pathology; the attributed mechanism of spread is 
expression of hyaluronidase like bacterial enzymes that helps to degrade the 
fascia. Unregulated multiplication of bacteria results in angiothrombotic 
microbial invasion with liquefactive necrosis of the superficial fascia. Thus the 
infection usually spreads along fascial planes. This leads to thrombosis of 
perforating nutrient vessels to the skin and progressive skin ischemia. 
This pathogenesisis responsible for the skin manifestations of evolving 
necrotising fasciitis
6
. Initially a radial phase with abrupt spread through the 
fascia predominates, followed by extensive undermining of apparently normal 
looking skin.  
As the condition progresses, ischaemic necrosis of skin evolves and 
ensues gangrene in subcutaneous fat, dermis and the epidermis, with 
progressive bullae formation, ulceration, and skin necrosis (Fig.2). 
  
 
Fig.2 Skin Necrosis with Ulceration 
Necrosis of the skin and deeper tissue may occur if there is severe hypoxia. Two 
examples are:  
• pressure necrosis resulting in decubitus ulcers, and 
• Compartment syndromes resulting in hypoxia and then necrosis in 
muscles confined within tight fascial bundles. 
CLASSIFICATION OF DEEP SOFT TISSUE INFECTION 
Clinical types are two: 
Type I: 
Type I necrotizing fasciitis refers to a mixed aerobic and anaerobic 
bacterial infection occurring most commonly in diabetic patients, following 
surgical procedures, and in those with peripheral vascular disease. 
Although the risk for an individual diabetic patient is low, this type of 
deep soft tissue infection is the most common form in the general population 
because the total number of people who have diabetes is large. 
  
Non-clostridial anaerobic cellulitis and synergistic necrotizing cellulitis 
are both variants of the same syndrome. It may not be important to distinguish 
these entities from one another because all occur in diabetic patients and are 
caused by mixed anaerobic and aerobic bacteria. 
Type II  
Type II is caused by group A streptococci and was earlier labelled as 
streptococcal gangrene.
7 
Of recent years, there has been a dramatic rise in the number of invasive 
infections, caused by group A streptococci including necrotizing fasciitis. In 
contrast to type I, this type may occur in any age group. Moreover Patients who 
do not have complicated medical illnesses may develop Type II necrotizing 
fasciitis. 
Predisposing factors include: 
¦ Intravenous drug abuse,  
¦ History of blunt trauma, 
¦ Non-steroidal anti-inflammatory agents, 
¦ Childbirth, 
¦ Chickenpox, 
¦ Muscle strain, or 
¦ wounds such as caused by a laceration or a surgical procedure. 
  
Based on the etiology 
NF with a known aetiology are classified as secondary NF. Bacterial 
entry occurs following some predisposing events such as cuts, abrasions, 
contusions, lacerations, burns, subcutaneous injections, bites, or operative 
incisions that causea break in the epidermis. In circumstances of occult infection 
such as an infected Bartholin cysts, perforated hollow viscus or as a 
complication of peri-rectal abscess, secondary NF can also occur. 
Idiopathic or Primary NF, occurs in the presence of a unknown or un-
identifiable etiologic factor. The exact pathogenesis still unknown. In view of 
early diagnosis and management, it is wiser to consider that idiopathic NF 
exists, and is a distinct clinical entity. 
CLINICAL FINDINGS 
Necrotizing fasciitis is a severe infection of subcutaneous soft tissues, 
principally the superficial and often the deep fascia. Usually it is an acute 
process but rarely may follow a sub-acute progressive course.  
Any part of the body can be affected by Necrotizing fasciitis but is most 
common on the extremities, especially the legs. Other sites of predilection are 
the perianal and groin areas, abdominal wall, and postoperative wounds. 
The gateway of infection usually is from a site of trauma such as an 
abrasion, laceration, insect bite, burn, a laparotomy performed in the presence of 
peritoneal soiling(e.g., penetrating abdominal trauma or perforated viscus) or 
  
another surgical procedure (e.g., haemorrhoidectomy, vasectomy), perirectal 
abscess, decubitus ulcer, or intestinal perforation. The intestinal perforation may 
be due to occult diverticulitis, recto sigmoid neoplasm, or a foreign body such 
as a chicken bone or toothpick. Necrotizing fasciitis of such intestinal sources 
may occur in the lower extremity, in the groin or abdominal wall. The spread of 
infection from intestinal sources to the lower extremity is via extension along 
the psoas muscle and to that of abdominal wall is via a colo-cutaneous fistula. 
In particular necrotizing fasciitis may develop in the clinical setting of 
alcoholism, diabetes mellitus, and parenteral drug abuse. 
The affected region is initially swollen, erythematous, shiny, without 
sharp margins, hot, exquisitely tender, and painful. Lymphangitis and 
lymphadenitis are uncommon.  
The process progresses rapidly over several days, with sequential 
integument colour changes from patches of red-purple to blue-grey. In 3 to 5 
days after onset, skin breaks down with the formation of bullae (containing 
thick pink or purple coloured fluid) and frank cutaneous gangrene (resembling a 
thermal burn) can be seen. (fig.3) 
 
 
 
 
Fig.3 Skin broken down with Thermal burn appearance 
  
The involved area by this time is no longer tender and becomes 
anaesthetic due to thrombosis of micro vasculature and destruction of 
superficial nerves that are normally located in the necrotic, undermined 
subcutaneous tissue. The onset of anaesthesia may precede the appearance of 
skin necrosis and suggests that the process is necrotizing fasciitis and not a 
simple cellulitis. Marked swelling and edema may cause a compartment 
syndrome with resultant extensive myonecrosis requiring prompt fasciotomy. 
Measurement of compartment pressure may aid the evaluation in early 
situations in which marked pain and swelling are present without concomitant 
skin changes that would indicate the diagnosis. 
Subcutaneous gas is often present in the polymicrobial form of 
necrotizing fasciitis, particularly in patients with diabetes mellitus. Systemic 
toxicity is prominent, and the temperature is elevated in the range of 38.9° to 
40.5°C (102°to105° F).On probing of the lesion with a haemostat through a 
small incision, the instrument passes easily along a plane just above the deep 
fascia. Such easy passage would not occur with ordinary cellulitis. 
The Centre for Disease Control and Prevention and The National 
Necrotizing Fasciitis Foundation has compiled the following as symptoms of 
NF: 
  
  
Early symptoms (usually within 24 hours): 
1. Commonly a trivial trauma or breech of skin has occurred (not necessarily 
appear infected) 
2. Pain at the site of injury. Pain may be sometimes in the same region or limb 
of the body 
3. Pain often disproportionate to the grade of injury 
4. Flu like illness then faces up with symptoms such as nausea, diarrhoea, 
dizziness, weakness, fever, confusion, and malaise 
5. Dehydration 
6. The biggest symptom is combined of all these symptoms. 
Advanced symptoms (usually occurs within 3–4 days): 
1. The affected area swells, and may develop a purplish rash 
2. Formation of blisters filled with blackish fluid 
3. The wound may  appear necrotic, associated with a dark mottled, flaky 
appearance. 
Critical symptoms (usually within 4–5 days): 
1. Hypotension 
2. State of septic shock from the toxins released by the bacteria. 
3. Unconsciousness. 
  
CLINICAL DIAGNOSIS 
Recognition of the characteristic features and the rapidly progressive 
clinical course of the disease aids in the diagnosis of necrotising fasciitis.
8 
Table.1Clinical stages of necrotising fasciitis 
Preceding history of soft tissue injury could be there commonly, from a 
blunt or penetrating trauma, animal or insect bite, postoperative infection, minor 
skin infection, or even injections that the patient has received as in 
subcutaneous insulin or illicit drugs. 
Overlapping diagnostic characteristics among cellulitis and necrotising 
fasciitis, often initially mislead the diagnosis to cellulitis, resulting in delayed 
management of much severe condition underneath. Not uncommonly, pain out 
of proportion to the elicited sign is the only early differentiating feature. In 
cellulitis, infection starts at the junction of dermis and superficial fascia, but in 
necrotising fasciitis it begins at the level of subcutaneous fat and deep fascia. 
The early stages of NF spares the epidermal and dermal layers.
9 
Erythema of 
skin and edema of the epidermal and dermal layers are therefore not obvious 
initially. Hypocalcemia (without tetany) may occur if subcutaneous fat necrosis 
is extensive. 
  
A number of symptoms and signs, however have been proposed that may 
help differentiate the two mentioned conditions. A Canadian study outlined 
patients with necrotising fasciitis as more likely to have a generalised 
erythematous rash and a toxic appearance.
10 
The pyogenic exotoxins and 
cytolysin produced by organisms are responsible for hypotension, disseminated 
intravascular coagulation and multi-organ failure. 
This study also described that patients with necrotising fasciitis were 
more likely to have thrombocytopenia at presentation (mean, 194.0 x 10
9
/L for 
necrotising fasciitis Vs 299.3 x 10
9
/L for cellulitis=0.03).
10 
Radiological studies help in assessing the extent of tissue infection, the 
presence of sub cutaneous gas aids in determining the extent of infection, 
especially in mixed aerobic – anaerobic or Clostridial infections. Plain 
radiographs may detect gas in soft tissues (fig.4), but Magnetic Resonance 
Imaging and Computed Tomography are superior at revealing the extent of 
affected area.  
 
 
Fig.4 Plain Radiographs showing subcutaneous gas 
  
CT scan features of Necrotizing Fasciitis include thickening and 
enhancement of deep fascia, fluid and gas in the soft tissue planes in and around 
the superficial fascia. (fig.5) 
 
 
Fig.5 CT Image showing impressive amount of gas extending up the fascial 
planes in the upper left leg and gluteal area. 
The features indicative of NF in USG include distortion and thickening of 
the deep fascia and fluid collections along the deep fascia. 
MRI is better to CT in distinguishing healthy and necrotic tissue. Features 
in MRI that are distinct for NF includes deep fascial fluid collections and 
thickening, and hyperintense T2W signal within the muscles.  
  
In MRI the sensitivity often exceeds its specificity that ensues in 
overestimation of extent of deep fascial involvement. Despite, a negative deep 
fascial involvement on MRI almost certainly excludes NF. 
However, routine application of Computed Tomography, Magnetic 
Resonance Imaging and frozen section biopsy in the evaluation of soft tissue 
infections is limited by cost and availability. Hence, Wong et al designed a 
simple scoring system, the Laboratory Risk Indicator for Necrotizing Fasciitis 
(LRINEC), which is based on routine laboratory investigations that are readily 
available at most centres, and that can help distinguish Necrotizing Fasciitis 
from other soft tissue infections. 
11 
The LRINEC score is calculated based on points assigned for six 
laboratory variables at the time of presentation including: C-reactive protein, 
haemoglobin, total leukocyte count, serum glucose, serum sodium, serum 
creatinine. 
 
 
  
  
Table.2 Laboratory Risk Indicator for Necrotizing Fasciitis 
(LRINEC) score  
Variable Score 
C- Reactive Protein, mg/L  
< 150 0 
≥ 150 4 
Total White cell count,  per mm
3 
 
< 15 0 
15 – 25 1 
> 25 2 
Hemoglobin, gm/dl  
> 13.5 0 
11 – 13.5 1 
< 11 2 
Sodium , mmol/L  
≥ 135 0 
< 135 2 
Creatinine , mg/dl  
≤ 1.6 0 
> 1.6 2 
Glucose , mg/dl  
≤ 180 0 
> 180 1 
The maximum score is 13.  
  
LRINEC Score Inference 
≥ 6 Suspicious of NF 
≥ 8 Strong prediction of NF 
 
The LRINEC score stratifies patients with softtissue infection into low, 
moderate and high risk categories of necrotizing fasciitis even when the clinical 
picture is equivocal. (fig.6) 
 
Fig.6 Risk Stratification using LRINEC Score 
Although Wong et al suggested LRINEC score as capable of detecting even 
clinically early cases of NF, other studies
12-15
 did not yielded satisfactory results 
so far to validate LRINEC score for routine use. 
 Limitations in earlier studies: 
1. Earlier studies were retrospective one. All variables of research interest 
may not be included in medical records since they might not be designed 
for research purposes or may contain inaccurate descriptions.  
  
However, to recommend the score for its routine use in the evaluation of 
soft tissue infections, LRINEC needs to be prospectively validated. 
2. The study cohort might include the subjects by the discharge diagnosis of 
necrotizing fasciitis. Less severe forms of the disease where the diagnosis 
was not made might have preferentially been missed. However, there may 
be some cases that are so fulminant where the diagnosis was unclear, 
would also affect their sample either way. 
3. Antibiotic therapy in other hospitals before the presentation to their ED 
might had an influence on the clinical course of disease. 
4. The inﬂammatory response may be blunted in patients with multiple 
comorbidities, thereof, the accuracy of the score had not been interpreted 
in such a cohort 
5. Unclear significance between the LRINEC score and the outcomes of 
necrotizing fasciitis, especially in terms of its predictability in limb loss 
and mortality 
  
  
SURGICAL DIAGNOSIS 
Tissue biopsy obtained at wound exploration and surgical debridement 
has remained the gold standard for detecting necrotising soft tissue infection. 
Biopsy diagnosis of NF is made when it shows infiltration of fascia by 
polymorphonuclear leukocytes. 
Integrity of tissue and depth of invasion during wound exploration can 
also be evaluated. Evidence of myonecrosis and fascial necrosis are indicative 
of necrotising infection. Definitive features of loss of fascial integrity along the 
tissue planes and presence of involvement of muscles are also diagnostic. 
 A bedside procedure that helps in diagnosis is the ‘finger test’. Under 
local anaesthesia, a 2-cm incision is made down to the deep fascia and a gloved 
finger is then probed at the level of the superficial fascia. Foul-smelling 
‘dishwater’ pus, lack of bleeding and least tissue resistance to finger dissection 
signifies a positive finger test, and are considered to be diagnostic of necrotising 
fasciitis.
16, 17 
MICROBIOLOGY 
The exudate from wound, on gram staining usually reveals a mixture of 
organisms or chains of gram-positive cocci in the case of streptococcal 
gangrene. Infection with a single pathogen occurs in only 15% to 29 % of 
patients.
18
  NSTI s are typically polymicrobial in nature.  
  
Staphylococcal and Streptococcal species are relatively common 
causative organisms in combination with anaerobes.  Vibrio and fungal 
pathogens have also been described as causing NSTI.  
Clostridial infections are typically monomicrobial, although they can be 
seen in combination with other bacteria. They are often characterised by 
myonecrosis and associated with a significantly worse prognosis. The most 
common organisms associated with Clostridial infections are clostridium 
perfringens, C.novyi and C. septicum.
18 
In most studies Clostridium difficile has 
also been isolated along with several members of Enterobacteriaceae from the 
wound drainage material. 
Commonly cultured gram positive organisms include coagulase negative 
staphylococci, group A haemolytic streptococci, Staphylococcus aureus, Staph. 
Epidermidis, enterococci, and Clostridial species. Mixed gram positive 
infections are present in approximately 10% of patients. Gram negative 
organisms such as Enterobacter species, Escolar, proteus sp, Pseudomonas, 
bacteroides sp, Serratia sp and mixed gram negative organisms are also 
common. The only other bacteria commonly reported as the sole cause of non 
Clostridial NSTI is β- haemolytic Streptococcus pyogenes, so called flesh eating 
bacteria and it does cause a rapidly spreading NSTI.
18 
 
 
  
COMPLICATIONS 
1. Delay in diagnosis 
2. Bacteraemia 
3. Delay in first debridement 
4. Acute renal failure  
5. ARDS/other respiratory failure 
6. Multiorgan system dysfunction 
7. Inadequate debridement 
8. Other infection (e.g., pneumonia, UTI) 
9. Clostridium difficile colitis 
10. Wound infection 
11. Decubitus breakdown/ulcer 
12. latrogenic source of necrotizing infection 
13. Seizure 
14. Antibiotic reaction 
15. Osteomyelitis 
16. Cardiopulmonary resuscitation 
17. Fecal wound soilage 
18. Heart failure 
19. Complications from HBO therapy 
  
Acute renal failure is defined as a rise in serum creatinine level to more than 
twice the baseline level or at least greater than 2 mg/dl. 
Adult respiratory distress syndrome can be defined as radiographic evidence 
of diffuse pulmonary edema, not found to be cardiogenic, and is associated with 
a PaO2/FiO2 ratio of less than 150 and decreased pulmonary compliance. 
Multiorgan system dysfunction, defined as objective evidence of acutely 
diminished function in two or more organ systems that requires urgent medical 
or surgical intervention. 
Complications from HBO therapy were uncommon which includes 
hypoglycemia, seizures, hemotympanum, and claustrophobia 
PREVENTION 
Centre for Disease Control has reported the following list of 
recommendations to prevent the disease: 
• Patients with sore throats should consult a doctor. 
• Patients with streptococcal throat infections  should stay home until 24 
hours after their last antibiotic dose. 
• Proper hand wash do prevent the spread of Group A Streptococcus (GAS) 
infection, especially before preparing food or eating, after sneezing and 
coughing. 
• Keeping the skin intact is essential. 
  
• Patients with infected wounds and fever should seek early medical care. 
• Wounds should be cleaned and monitored regularly for signs of infection 
(redness, swelling, drainage, pain). 
MANAGEMENT 
The three essential themes in treatment are surgical debridement, 
intensive supportive care and appropriate antibiotics. Some patients require 
mechanical ventilation and others need hemodialysis. Gross hypotension and 
diffuse capillary leak often necessitates vigorous amounts of intravenous fluids 
(10–20 litres per day), although anasarca is a common complication. In some 
patients blood pressure improves with intravenous fluid alone. Vasopressors 
such as dopamine may be useful, but there is meagre information from clinical 
studies in this specific infection. Although potent vasoconstrictors like 
epinephrine may improve blood pressure, symmetric gangrene may ensue, 
partly as a result of the drug and partly as a result of poor perfusion caused by 
the bacteria, toxins and endogenous mediators. 
The "Surviving Sepsis Campaign," a multidisciplinary group that worked 
to develop treatment recommendations, has published guidelines incorporating 
evidence-based treatment strategies most recently in 2008.
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These guidelines are summarized below: 
Initial evaluation and infection issues 
Initial resuscitation: Begin resuscitation immediately in patients with                       
hypotension or elevated serum lactate with 
resuscitation goal    of CVP 8-12mmHg, mean arterial 
pressure of ≥ 65 mmHg,    and urine output of ≥ 
0.5ml/kg per hour 
Diagnosis      :  Obtain samples for cultures before antibiotic   
but antibiotic therapy not be delayed. 
 
Antibiotic Therapy  :  Begin IV antibiotic therapy as early as possible: 
should be within the first hour after recognition of 
severe sepsis / septic shock; use broad spectrum 
antibiotic regimen with penetration into presumed 
source; reassess regimen daily; discontinue antibiotics 
in 7- 10 days for most infections; stop antibiotics for 
non-infectious issues. 
Source control: The anatomic site of infection should be established 
earlier. After initial resuscitation implement source 
control measures as soon as possible. Potentially 
  
infected intra vascular access devices need to be 
removed. 
HEMODYNAMIC SUPPORT AND ADJUNCTIVE THERAPY 
Fluid Therapy  : Fluid resuscitate using crystalloid or colloid, 
using fluid volumes of 1000 mL (crystalloid), 
target CVP of 8–12 mmHg. 
Vasopressors/inotropic therapy: Maintain MAP of ≥65 mmHg; centrally 
administered nor epinephrine or dopamine are 
first-line choices; dopamine should not be used 
for "renal protection"; insert arterial catheters for 
patients requiring vasopressors. Do not increase 
cardiac index to predetermined supranormal 
levels. 
Steroids : Consider IV hydrocortisone (adult dose ≤300 
mg/d) for septic shock when hypotension is 
refractory to fluids and vasopressors. 
Recombinant human activated protein C:  
Consider rhAPC in adult patients with sepsis-induced 
organ dysfunction and high risk of death. 
  
  
OTHER SUPPORTIVE THERAPY 
Administration of Blood product: 
Packed cell transfusion if hemoglobin decreases 
to <7.0 g/dL. 
Mechanical ventilation : Target an initial tidal volume of 6 mL/kg  
body weight and plateau pressure of ≤30 cm 
H2O in patients with acute lung injury. Use 
PEEP to avoid lung collapse. Use a weaning 
protocol to evaluate the potential for 
discontinuing mechanical ventilation. 
Pulmonary artery catheter is not indicated for 
routine monitoring. 
Glucose control :  Control hyperglycemia in patients with  
severe sepsis with IV insulin. 
Prophylaxis :  Use stress ulcer (proton pump inhibitor or  
H2 blocker) and deep venous thrombosis (low-
dose unfractionated or fractionated heparin) 
prophylaxis. 
Limitation of support:  Patients and families need to be aware of 
advance care planning. 
  
CVP = central venous pressure; MAP = mean arterial pressure;  
PEEP = positive end-expiratory pressure;  
rhAPC = recombinant human activated protein C. 
 
Aggressive nutritional support is mandatory in all patients after 
debridement. Recommended allowances of calories would be double  their basal 
caloric requirements given orally or parenterally. Nutritional support runs the 
risk of fewer complications with lower morbidity and mortality rates. Pre and 
post-operative pain control is also an important part of management and should 
be individualised for each patient. 
PHARMACOTHERAPY 
Antibiotic selection is difficult in patients who have rapidly progressing 
infection. Antibiotic therapy of NSTI is specifically directed to provide broad 
spectrum coverage for gram positive organisms, gram negative organisms and 
anaerobes.  
The choice of empiric antibiotics is controversial and is dependent 
primarily on personal preference. Many of the most commonly used regimens 
include (1) penicillin and an aminoglycoside plus clindamycin, (2) imipenem-
cilastatin, or (3) ampicillin plus sulbactam (Unasyn) plus an aminoglycoside.  
  
Some practitioners select an antipseudomonal penicillin or, in the patient 
who is allergic to penicillin, vancomycin. Initial empiric treatment can 
subsequently be adjusted according to bacterial sensitivities on tissue cultures. 
Recent studies describes that clindamycin is better to penicillin for 
treatment of experimental necrotizing fasciitis or myonecrosis caused by group 
A streptococci.
20
 It seems likely that penicillin failure is due to the decreased 
expression of penicillin-binding proteins during the stationary phase of bacterial 
growth. 
 Clindamycin may be more efficacious because: 
¦ it suppresses toxin production, 
¦ it has a long post antibiotic effect. 
¦ it is not affected by inoculum size or stage of growth 
¦ it inhibits M-protein synthesis and facilitates phagocytosis of Streptococcus 
pyogenes 
Neutralization of streptococcal toxins is a desirable therapeutic goal and is 
advocated by some experts.
21 
Some authorities recommend also giving immune 
globulin (400 mg/kg/d intravenously for 5 days) for documented streptococcal 
toxic shock syndrome.
21 
 
 
  
SURGICAL INTERVENTION 
The major emphasis in treatment is inevitably surgical. Suspicion should 
be directed toward any wound incurred out of doors and contaminated with a 
foreign body, soil, or faeces and any wound in which tissue (particularly 
muscle) has been extensively injured. This type of wound should be carefully 
examined, with the patient under sufficient anaesthesia to permit full inspection 
and debridement of devitalized tissue, including muscle. 
It is often difficult to distinguish necrotic from edematous tissue. Careful 
daily inspections of the wound will determine whether repeated debridement 
will be necessary. Daily debridement under anesthesia may be required, since 
these lesions are extensive and the degree of tissue viability is often difficult to 
assess in the operating room (fig.7). Tight fascial compartments must be 
decompressed. Wide-open drainage is essential and may require extensive 
denudation.  
A functional extremity can usually be salvaged in fasciitis; if not, 
amputation can be safely performed later. 
  
 
Fig.7 Raw area right leg after surgical debridement 
It is important to avoid confusing fasciitis with deep gangrene. It is a 
tragic error to amputate an extremity when removal of dead skin and fascia will 
suffice. Immediate amputation is necessary when there is diffuse myositis with 
complete loss of blood supply or when adequate debridement would clearly 
leave a useless limb.  
When viability of the remaining tissue is assured and the infection has 
been controlled, soft tissue deficits can be covered with skin grafts.(fig.8) 
 
 
 
 
Fig.8 Skin graft applied to cover the soft tissue deficit 
  
The following factors favours limb salvage surgery: 
Table.3 Factors favouring limb salvage surgery versus amputation 
 
HYPERBARIC OXYGEN THERAPY 
Hyperbaric oxygen (HBO) is generally regarded as an important adjunct 
that can be used in the management of Clostridial myonecrosis or gas 
gangrene.
22 
The principle of hyperbaric oxygen therapy is that all necrotizing 
infections have reduced oxygen tension in the tissues, ischemia and subsequent 
reduction in the host cellular immunity. Increased oxygen partial pressure has 
been associated with the reversal of basic pathophysiologic mechanism of 
necrosis. Increased oxygen tension also reverses ischemia and thereby improves 
host defence mechanisms. Furthermore, it facilitates the transport of drugs 
across the bacterial cell wall and thus enhances the action of various antibiotic 
agents.
22-24 
 
  
Despite these facts, the efficacy of HBO for other NSTIs remains 
controversial. The studies on the efficacy of HBO therapy and its outcome with 
respect to length of hospitalisation and mortality have failed to show 
statistically significant differences. As a result, HBO is not a mandatory 
component of therapy, but its use should never delay definitive surgical care. 
An HBO treatment regimen usually consists of wound exposure at 2.5 to 
3.0 atmospheres and breathing 100% oxygen for 90 minutes every 8 hours in 
the first 24 hours of infection, and then twice daily. HBO treatment is continued 
for a minimum of 5 days and is discontinued when the patient is stable and has 
no evidence of ongoing necrosis. 
PROGNOSIS AND OUTCOME 
The mortality associated with NSTI has been in the range of 16% to 45%. 
Multiple prognostic factors have been identified, including the presence of 
clostridial infection.
25 
For patients who survive no matter what their premorbid state – major 
disfigurement and lengthy rehabilitation are common. 
 
 
 
  
Table.4 Prognostic score to predict mortality in patients with NSTI at the 
time of first assessment 
VARIABLE (on admission) NO. OF POINTS 
Heart Rate > 110 beats/min 1 
Temperature <36 °C 1 
Creatinine > 1.5mg/dl 1 
Age 3 
WBC > 40,000 3 
Hematocrit> 50 3 
 
From Anaya DA, Bulger EM et al: Predicting mortality in Necrotizing Soft Tissue Infections : A 
clinical score. Paper presented at the 25th Annual Meeting of the Surgical infection Society, May 2005 
 
NO. OF POINTS MORTALITY RISK 
0- 2 6% 
3-5 24% 
≥ 6 88% 
 
  
  
CLINICAL FORMS OF NECROTIZING FASCIITIS 
Fournier's gangrene 
'Fournier's gangrene' may be caused by the penetration of the GIT or 
urethral mucosa by bacteria. It is an aggressive infection caused by Gram-
negative, aerobic bacteria, enterococci and anaerobic bacteria such as 
Bacteroides spp. and peptostreptococci. Extremes of pain may herald the onset 
of infection which spreads to the anterior abdominal wall and muscles of the 
gluteal region; in males, infection frequently extends to the scrotum and 
penis.(fig.9) Surgical inspection, placement of drains and appropriate surgical 
debridement are necessary for both diagnosis and treatment. Antibiotic 
treatment should be based upon culture and sensitivity and Gram staining 
information when available. An appropriate empiric regimen would be either 
ampicillin or ampicillin and sulbactamin combination with metronidazole or 
clindamycin. Alternatively, Gram-negative coverage is advisable if the patient 
had been hospitalised in the past or antibiotics have been used recently. This 
could be alleviated by substitution of ticarcillin-clavulanic acid or piperacillin-
tazobactam for ampicillin or by addition of a fluorinated quinolone or 
aminoglycoside. 
  
  
   
 
 
 
Fig.9 Fournier’s gangrene 
Meleney's synergistic gangrene 
This is a rarer variety occurring in postsurgical state of patients. The 
lesions are slowly expanding, ulcerated and limited to the superficial fascia 
resulting in a combination between Staph. aureus and microaerophilic 
streptococci synergism. As in other forms of necrotizing infection, antibiotic 
therapy together with surgical debridement is the mainstay of treatment. 
Non-Clostridial anaerobic cellulitis 
In non-Clostridial anaerobic cellulitis, infection is associated with tissue 
gas producing aerobic organisms and mixed anaerobes. This foul smelling 
infection is associated with Diabetes Mellitus and differs from Clostridial 
cellulitis. Surgical exploration is required to distinguish this condition from 
necrotizing cellulitis, myonecrosis and necrotizing fasciitis by Clostridium spp. 
  
  
Clostridial cellulitis 
In Clostridial cellulitis, recent surgery or local trauma precedes infection. 
Clostridium perfringens is the most common species causing this entity. The 
fascia and deep muscle are spared whereas gas is invariably found in the skin; 
although clostridial cellulitis is different from clostridial myonecrosis in that 
there is less systemic toxicity, it is mandatory that thorough debridement and 
surgical exploration be performed to distinguish these entities. MRI or CT scans 
as well as a serum creatinine phosphokinase assay may also be useful for 
determining whether muscle tissue is involved. Treatment is discussed below 
under gas gangrene. 
Clostridial gas gangrene 
The following are types of Clostridial soft tissue infections 
3
:  
1. Simple wound contamination  or colonization, 
2. Cellulitis by anaerobic organisms 
3. Clostridial gas gangrene. 
The first type, simple wound contamination or colonization, does not 
progress to true infection for various reasons (e.g. there may be insufficient 
devitalized tissue to promote infection or there may be effective host responses 
or effective medical and surgical management). Contamination is a very 
common occurrence; 30–80% of open wounds has species of clostridial origin.
26 
  
Anaerobic cellulitis occurs in the presence of  devitalized tissue in  wound, 
sufficient for growth of Clostridium perfringens or other strains. Although gas 
extends along fascial planes, bacteremia and healthy tissue invasion do not 
occur. Appropriate removal of devitalized tissue at the prompt time, is all that is 
necessary for cure and nearly nil mortality. 
The third type is myonecrosis or clostridial gas gangrene. This is defined as 
an acute invasion of muscle that is healthy and not damaged by previous 
ischemia or trauma. 
 It is divided into three different subtypes: 
1. Traumatic gas gangrene, 
2. Spontaneous or non-traumatic gas gangrene, and 
3. Recurrent gas gangrene caused by C. perfringens. 
Gas gangrene caused by trauma is the most common (70% )subtype. It 
develops when a deep, penetrating injury compromises perfusion that creates an 
anaerobic environment which is ideal for proliferation of clostridial organisms.  
80% of such infections contain Clostridium perfringens; and the remaining 
cases reveal other strains such as Clostridium histolyticum, Clostridium 
septicum, Clostridium bifermentans, Clostridium novyi, Clostridium tertium 
and Clostridium fallax. Other predisposing conditions of traumatic gas gangrene 
are biliary tract and bowel surgery, intramuscular injection of adrenaline, illegal 
  
abortion, retained placenta, prolonged rupture of the membranes and 
intrauterine foetal demise or missed abortion in postpartum patients.  
Spontaneous or non-traumatic gas gangrene is less common. This is often 
caused by the aerobic species Clostridium septicum.  
Recurrent gas gangrene caused by Clostridium perfringens is the least 
common type. This occurs in non-penetrating injuries at sites of previous gas 
gangrene.
27 
Traumatic gas gangrene 
Pathogenesis 
The initial trauma introduces organisms into the deep tissues and 
produces an anaerobic niche with a sufficiently low redox potential and acid pH 
for optimal growth of clostridial organisms. Necrosis progresses within hours. 
At the junction of normal tissues and necrotic, few polymorpho nuclear 
leukocytes are present, yet pavementing of these cells along the endothelium is 
apparent within capillaries and smaller arterioles and post capillary venules. 
Later in the course of the illness there is leukostasis within large vessels. Thus, 
the unique histopathology appearance in clostridial gas gangrene is an early 
influx of abundant polymorpho nuculear leukocytes without adjacent tissue or 
vascular destruction. This picture is in contrast to that seen in pyogenic 
organisms causing infection. Of late, it is suggested that s-toxin, at the site of 
infection, destroys host tissues and inflammatory cells.  
  
The s-toxin promotes dysregulated adhesive interactions between 
polymorpho nuclear leukocytes and endothelial cells within circulation or in 
adjacent tissues and primes leukocytes for increased respiratory burst activity.  
This results in injury to the endothelial layer, vascular leukostasis and 
regional hypoxia of tissues. Such hypoperfusion creates an anaerobic 
environment and contribute to the increased rate of tissue margin destruction. 
This is characteristic of clostridial gangrene. 
Shock associated with gas gangrene may be attributed to the effects of 
released toxins. This effect may be a direct or indirect effect.  Alpha toxin, a 
phospholipase C, suppresses cardiac contractility ex vivo and may contribute to 
hypotension. Theta toxin (a cholesterol-binding cytolysin) causes 'warm shock', 
which is defined as a markedly reduced systemic vascular resistance combined 
with a markedly increased cardiac output.
28 
 Theta toxin accomplishes this by enhancing the release of endogenous 
mediators that cause relaxation of blood vessel smooth muscle, such as the lipid 
autacoids prostacyclin or platelet-activating factor. Tone of vessels reduces 
rapidly. A compensatory increase in cardiac output or rapid expansion of the 
intravascular blood volume occurs in order to maintain adequate tissue 
perfusion. This adaptive mechanism is markedly seen in Gram-negative sepsis, 
however similar compensatory mechanism may not be adequately possible in 
  
shock induced by C. perfringens as because of alpha toxin directly suppresses 
on myocardial contractility.  
Prevention 
• Aggressive debridement of devitalized wound and early repair of 
any compromised blood supply helps to reduce the onset of gas 
gangrene in contaminated deep wounds.  
• Prolonged tourniquet duration, Intramuscular adrenaline and 
surgical closure of dirty traumatic wounds should be avoided.  
• Patients with compound fractures are at particular risk of gas 
gangrene especially if the wound is surgically closed immediately. 
• Patients who have contaminated wounds should receive adequate 
and appropriate prophylactic antibiotic cover. 
Clinical findings 
The initial symptom is abrupt onset of severe pain in the site of recent 
surgery or trauma. The mean incubation period is often less than 24 hours, but 
may vary probably depending on the degree of wound contamination or bowel 
contents spillage and the extent of vascular injury with low tissue oxygen 
tension. 
Initially pallor skin changes to bronze, then purplish red, becoming tense 
and  tender. Bullae may beclear, red, blue or purple. 
  
Gas in tissue may be obvious from clinical examination and soft tissue 
imaging. Interestingly, none of the CT, MRI has proved to be more sensitive or 
specific than the physical finding of crepitus in the soft tissue. However, 
imaging procedures are particularly useful for demonstrating gas in deeper 
tissue such as the uterus. 
Features of systemic toxicity develop rapidly; these include diaphoresis, 
fever, tachycardia, followed by shock and multiple organ failure. Shock is 
present in 50% of patients at the time they present to the hospital. Bacteremiais 
seen in 15% of patients and can be associated with brisk hemolysis.  Not all 
cases of C. perfringens bacteremia are associated with gas gangrene. Isolates 
from blood showing C. perfringens and C. septicum were associated with 
clinically significant wound infection. 
Further complications of clostridial myonecrosis include hypotension, 
liver necrosis with jaundice and renal failure. Hemoglobinuria and 
myoglobinuria, causes renal failure but it can be a result of hypotension induced 
acute tubular necrosis. Renal tubular cells are probably directly affected by 
toxins, but this has not been proved.  
Diagnosis 
Factors supporting the diagnosis are worsening of pain at the site of 
previous injury or surgery, together with signs of systemic toxicity and gas in 
the tissues.  
  
Definitive diagnosis is done by demonstrating Gram-variable rods at the 
affected site. Although clostridia stain Gram positive when obtained from 
bacteriologic media, when visualized from infected tissues they often appear 
both Gram positive and Gram negative. C. perfringens may appear to be 
encapsulated in fresh specimens. 
Surgical exploration is inevitable. The exposed muscle appears 
edematous, may be an abnormal reddish-blue to black colour and does not bleed 
or contract when stimulated. Usually, some degree of fascial and cutaneous 
necrosisis also present. Organisms amongst degenerating muscle bundles  with 
absence of acute inflammatory cells are evident in microscopic examination. 
Management 
Excellent in vitro activity against C. perfringens and other clostridia have 
been demonstrated in Penicillin, tetracycline, chloramphenicol, metronidazole, 
clindamycin, and numerous cephalosporins. 
Randomized trials in humans to compare the efficacy of different 
antibiotics yet to be conducted. Most literature, based on in-vitro data states that 
penicillin is the drug of choice. However, experimental studies in mice have 
shown greatest efficacy for clindamycin and least for penicillin. 
Erythromycin, rifampin, chloramphenicol, tetracycline and metronidazole 
are agents with efficacy greater than penicillin. Survival advantage was 
observed in animals receiving both clindamycin and penicillin; in contrast, 
  
antagonistic effect was observed with combination of penicillin and 
metronidazole. A combination of penicillin and clindamycin is advisable since 
upto5% of strains would be resistant to clindamycin. Use of combination of 
tetracycline and penicillin is also advocated based on various experimental 
studies. Thus, in the absence of clinical trial in humans, the best treatment 
would be to administer a combination of clindamycin or tetracycline with 
penicillin. Thorough surgical debridement is always mandatory to improve 
survival, preserve limbs and prevent further complications. 
 Although some studies have reported better efficacy with HBO therapy 
when combined with antibiotics and surgical debridement, the use of hyperbaric 
oxygen is controversial. The Hyperbaric oxygen therapy, of theoretically, 
inhibits bacterial growth, preserve marginally perfused tissue and inhibit toxin 
production. Animal studies have demonstrated that HBO alone can be effective 
treatment if the inoculum is small and treatment is begun immediately. On 
contrary, other studies have reported that HBO when combined with penicillin 
was only of slight benefit. However, survival was better with clindamycin alone 
than with HBO alone, penicillin alone or HBO plus penicillin together. 
Strategies in therapy have been directed against toxin expression and 
proadhesive molecules. Target of toxin expression is accomplished in vivo, by 
neutralization with specific antitoxin antibody or by toxin synthesis inhibition.  
Currently, antitoxin is no longer available. Endogenous proadhesive molecules 
  
may be the promising  future targeted strategy in attenuating toxin induced 
tissue injury. 
Prognosis 
Gas gangrene of an extremity have a better prognosis than those e truncal 
or intra-abdominal gas gangrene, because it is hardly feasible to debride such 
lesions adequately.
29 
Truncal gangrene with associated bacteraemia and 
intravascular hemolysis have the greatest likelihood of progressing to shock and 
death.
33, 34
 
Spontaneous, non-traumatic gas gangrene due to Clostridium septicum
 
Pathogenesis 
Predisposing factors include: 
¦ Leukemia, 
¦ Cancer chemotherapy, 
¦ Colonic carcinoma, 
¦ Diverticulitis, 
¦ Lymphoproliferative disorders, 
¦ Gastrointestinal surgery, 
¦ Radiation therapy, and AIDS 
  
Neutropenia associated with spontaneous gas gangrene is due to C. 
septicum and in such cases commonly found lesions are necrotizing 
enterocolitis, cecitis or distalileitis. These factors allows bacteremia; 
consequently, the aero tolerant C. septicum can establish in healthy tissues.
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The distinct feature of C. septicum from the toxin of C. perfringensis that 
a- toxin of C.septicum has no phospholipase activity. Active immunization 
against a-toxin significantly protects against viable C. septicum experimentally. 
however, the recent cloning and sequencing of this toxin may facilitate further 
studies in this area. 
Clinical features 
The disease has often abrupt onset, with excruciating pain, although the 
symptoms of the patient usually is heaviness or numbness. Sometimes, 
confusion or malaise may be the initial presentation. Rapid progression of 
gangrene frequently sets in. Haemorrhagic or purplish fluid filled bullae make 
their appearance. Vascular compromise of the surrounding area also causes a 
purple hue of the skin.  
Diagnosis 
Histopathology of muscle and connective tissues reveals cell lysis and gas 
formation; with conspicuous absence of inflammatory cells. 
In Spontaneous gangrene, the onset of bacteraemia usually precedes 
cutaneous manifestations unlike the traumatic gangrene.  
  
Other common conditions presenting with fever and extremity pain in the 
absence of cutaneous signs of gas gangrene that should be considered are deep 
vein thrombophlebitis or cellulitis. 
Management 
Human trials evaluating the efficacy of Hyperbaric Oxygen or various 
antibiotics for treating spontaneous gas gangrene is yet to be done. Study data 
indicates C.septicumas susceptible to penicillin, tetracycline, erythromycin, 
clindamycin and metronidazole. The aero tolerance of C. septicum mayreduce 
the likelihood that HBO therapy would be effective. 
Prognosis 
The first 24 hours being the most crucial period comprising of majority of 
deaths with the mortality ranges from 67% to 100%,.
31, 32
 Unfavourable factors 
include underlying malignancy and conditions causing compromised immune 
status. Survivors of bacteraemia or spontaneous gangrene caused by C. 
septicum should undergo appropriate diagnostic studies of the gastrointestinal 
tract. Occasionally, this has led to detection and cure of an unsuspected 
malignancy that might otherwise have been fatal. 
 
 
 
  
Clostridium sordellii infections 
The characteristic clinical features of C. sordellii infection are edema, 
leukemoid reaction, hemoconcentration, absence of fever and even shock in 
later stages combined with multiple organ failure. Often C. sordellii infections 
develop after gynaecologic procedures or in postpartum period and mostly 
represent endometrial infection. Rarely, other cases have occurred at sites of 
minor injuries such as lacerations of the soft tissues of an extremity. Recently, 
outbreaks of C. sordellii and C.novyi infections have been described among 
intravenous drug users in Scotland, Ireland and England. Patients have 
presented with severe soft tissue infections with shock with a case fatality rate 
of 20–30%. Absence of pain in C.sordellii is typical feature. The absence of 
fever and the paucity of signs and symptoms make early diagnosis difficult in 
such infections 
Clostridium tertium infections   
Clostridium tertium has been associated with spontaneous myonecrosis; 
however,  bacteremia in immuno compromised hosts  is more common with this 
infecton. Bacteremia probably arises from bowel sources, and the presence of 
the organism in the bowel may be partly related to its relative resistance to 
penicillin, clindamycin and cephalosporins. Clostridium tertium usually 
responds to metronidazole, chloramphenicol and vancomycin.  
 
  
Because this organism can grow in an aerobic environment, it can be by 
mistake disregarded as a contaminant. 
Pyomyositis 
Most cases of pyomyositis occur in tropical areas. Local trauma is a 
common predisposing factor. Initially, seeding of traumatized muscle occurs 
and physical findings are not usually helpful. Within 10–20 days, fever, chills, 
muscle pain and tenderness are manifest. Most patients seek medical care at this 
stage and a diagnosis can be established by appropriate imaging studies, needle 
aspiration or exploration. Patients in whom a diagnosis has not been made may 
progress to shock and organ failure, though these complications are uncommon. 
Staphylococcus aureus is the most common cause of pyomyositis in tropical and 
non-tropical areas, and among HIV-positive patients.  
Hospitalized immuno compromised patients who are HIV negative 
occasionally develop pyomyositis caused by Gram negative bacteria.  
Surgical drainage of the abscess and empiric administration of parenteral 
antibiotics such as nafcillin or cephalosporins are reasonable treatments since 
most cases are caused by Staph. aureus. Definitive treatment can then be 
established based on cultures and sensitivities. Due to an increase in the 
prevalence of methicillin-resistant Staph. aureus, it may be necessary to use 
vancomycin or linezolid empirically pending sensitivity results. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
______________________________________________________________________________________________________________________ 
 
  
A Prospective Observational study was conducted in Coimbatore Medical 
College Hospital from November 2012 to November 2013 among Patients 
admitted to the surgical wards with severe soft tissue infections. 
Inclusion Criteria: 
All Patients above 18 years of age with severe soft tissue infections. 
Exclusion Criteria: 
1. Patients ≤ 18 years age 
2. Patients referred from other institutions  
3. Patients who needs multiple admissions due to soft tissue infection, only 
the first admission be considered. 
4. Patients with features of Necrotizing Fasciitis on presentation. 
5. Patients with Surgical site infections. 
Interventions: 
 Age, sex, clinical manifestations, site and aetiology of infection, 
predisposing factors, comorbidities, vital signs, laboratory parameters at 
the time of admission, medication being taken at the time of admission 
and microbiology of wound and blood cultures had been recorded.  
 Aggressive surgical debridement, culture of pus, tissue biopsy, 
radiological imaging, antibiotic therapy, treatment of complication, 
amputation or skin grafting were strategized for management. 
  
 The interval between contact and admission, LRINEC score(Table -2 ), 
risk categorization (Fig 6), time interval between admission and ﬁrst 
surgery, the number of surgical procedures, the need for amputation, the 
length of hospital stay and the mortality rate had been documented. 
 All variables were statistically analysed further to evaluate the 
significance of LRINEC score in predicting the clinical outcomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Observation and Results 
 
  
Total of 60 patients with soft tissue infections were included in this study. They 
were evaluated on the basis of Laboratory Risk Indicator for Necrotizing 
Fasciitis (LRINEC). Based on their LRINEC score, the patients were 
categorised as Low, Intermediate and High Risk for the onset of Necrotizing 
fasciitis. Patients in each category were appropriately managed and their 
outcomes are discussed below. 
Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score  
Variable Score 
C- Reactive Protein, mg/L  
< 150 0 
≥ 150 4 
Total White cell count,  per mm
3 
 
< 15 0 
15 – 25 1 
> 25 2 
Hemoglobin, gm/dl  
> 13.5 0 
11 – 13.5 1 
< 11 2 
Sodium , mmol/L  
≥ 135 0 
< 135 2 
  
Creatinine , mg/dl  
≤ 1.6 0 
> 1.6 2 
Glucose , mg/dl  
≤ 180 0 
> 180 1 
 
The maximum score is 13.  
 
RISK CATEGORIZATION OF PATIENTS BASED ON LRINEC SCORE 
The study population of 60 patients were categorised based on the LRINEC risk 
stratification as mentioned below : 
 
 
 
LRINEC SCORE 
5 OR LESS 
6 - 7 
8 OR MORE 
 
About 75% of patients with soft tissue infections were categorized as low 
risk for progression to Necrotizing Fasciitis. About 12% and 13% of patients 
with soft tissue infections were categorized as intermediate and high risk for 
progression to Necrotizing Fasciitis re
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SEX WISE DISTRIBUTION 
The study population with soft tissue infections comprises 70% males and the 
rest being females. 
AGE WISE RISK DISTRIBUTION
The Patients with soft tissue infections were categorized by their 
LRINEC Score as Low, Intermediate and High risk for the occurrence of 
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Necrotizing Fasciitis. It was found in this study that larger proportion of soft 
tissue infections had been in 5
tissue infections in their 50s and 60s were more at low risk for Necrotizing 
Fasciitis than those at the rest of age. However age beyond 50 years confers the 
high risk for Necrotizing Fasciitis, as evident in this st
SITE DISTRIBUTION OF SOFT TISSUE INFECTIONS
Extremity was the most common site involved in soft tissue infections 
followed by scrotum and perineum. Lower limb was the more common site of 
infection than Upper limb. 
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Scrotum Perineum
36 6 3
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ETIOLOGY FOR SOFT TISSUE 
Among the Patients studied, about 78 % of the patients had their illness of 
spontaneous onset and 22% had a preceding history of injury, more often a 
thorn / nail prick or a road traffic accident or a history of fall. 
  
22%
INFECTIONS 
 
78%
Spontaneous
Injury
 
 
TISSUE DIAGNOSIS OF NF
The tissue biopsy obtained 
debridement is the gold standard for 
infections. Biopsy diagnosis of NF is made when it shows infiltration of fascia 
by polymorpho nuclear leukocytes.
Tissue biopsy had been obtained in all patients in the study group and the 
results of biopsy is summarised below:
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N
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diagnosing necrotising soft tissue
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NUMBER OF DEBRIDEMENT REQUIRED FOR EACH CATEGORY
The number of surgical debridement that were required for patients in 
each category is summarised below:
 
The Patients under high risk category required higher number of surgical 
debridement than the low and intermediate risk groups. And nearly 50% of 
patients in low risk group did not require debridement. Patients in Intermedi
risk group had required at least two debridement for the regression of their soft 
tissue infection. 
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OUTCOME IN EACH CATEGORY
Forty five Patients in Low risk category had their soft tissue infection 
regressed with IV antibiotics, anti
cases and surgical debridement in 23 cases. Of them, Skin grafts were applied in 
eight patients.  
All seven patients in Intermediate risk were improved with no morbidity 
or mortality. Three of them required split skin graft
Three of eight patients in High risk category improved with multiple 
surgical debridement along with graft application. Two Patients required 
amputation and three died despite all resuscitative measures.
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CO MORBID FACTORS 
SEX DISTRIBUTION FOR COMORBIDITI
Comorbidities such as Diabetes Mellitus, Chronic Renal Failure, 
Systemic Hypertension, Peripheral Vascular disease were more commonly 
found in males than females.
DM was the leading comorbid
study population.  
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 factor in both primary and secondary NF in our 
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RISK CATEGORIZATION AMONG DIABETIC PATIENTS
Patients with pre-existing or currently diagnosed Diabetes Mellitus were 
categorised based on their LRINEC score. 
 
Seven of eight patients in high risk group were diabetics. Twelve and four 
patients were diabetics in Low and Intermediate risk groups respectively.
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POSITIVE TISSUE DIAGNOSIS IN DIABETICS
Tissue biopsy had been obtained in all diabetic patients with severe 
infections of soft tissue and the results are summarised below:
None of the diabetics in low and intermediate risk showed positive for 
tissue diagnosis. Five of seven diabetics in high risk group had positive tissue 
diagnosis for necrotizing fasciitis.
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OUTCOME OF DISEASE AMONG DIABETIC PATIENTS
Disease outcome among
summarised below: 
All twelve diabetics in low risk group had improved with appropriate 
management. All of the diabetics in intermediate group have improved with IV 
antibiotics and surgical debridement.
Among the diabetic patients in high risk group, two got improved with 
resuscitative measures and multiple surgical debridement; two required 
amputation of the affected part and three (as in entire study group) succumbed 
to death.  
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OUTCOME OF DISEASE AMONG PATIENTS
 
Three patients with coexisted Diabetes and CRF were dead. CRF alone 
did not found to influence the outcome of necrotizing fasciitis.
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Discussion 
______________________________________________________________________________________________________________________ 
 
  
Necrotizing soft tissue infections are fatal progressive infectious 
processes, most prevalent among alcoholics, impoverished obese diabetic 
patients and injection drug users, with a varied spectrum of clinical course 
associated with severe sepsis. The associated systemic inﬂammatory response 
syndrome in the setting of sepsis causes changes in the biochemical parameters 
in a predictable manner.  
The LRINEC score is a measure of these changes and predicts the 
presence of necrotizing fasciitis. Other soft tissue infections (e.g. cellulites and 
abscesses) rarely cause an inﬂammatory state severe enough to cause such 
disturbances in the laboratory variables.  
This Prospective study of 60 patients with soft tissue infections included 
forty two males (70%) and eighteen females (30%). The mean age was 55.3 
years. Diabetes mellitus was the most common co-morbidity (23 cases). Other 
comorbidities included Chronic Renal Failure (6 cases), Systemic Hypertension 
(4 cases), Peripheral vascular disease (1 case).  The important manifestations at 
presentation were erythema, edema, tenderness, bullae, necrosis tachycardia and 
hypotension. Extremity was the most common site involved (51 cases) followed 
by scrotum (6cases) and perineum (3 cases). About 78% of patients had soft 
tissue infection of unknown origin and 22% were attributed injury as a cause.  
 
 
  
Table.5The characteristics of the study group  
RISK 
CATEGORY 
NO. 
OF 
CASES 
T
IS
S
U
E
 D
IA
G
N
O
S
IS
 
NO. 
OF 
CASES 
M F 
SITE 
TREATMENT GIVEN OUTCOME 
S
C
R
O
T
U
M
 
P
E
R
IN
E
U
M
 
E
X
T
R
E
M
IT
Y
 
LOW RISK 45 
+ 7 7 0 5 0 2 
WOUND DEBRIDEMENT, 
GRAFT IN 2 CASES.            
2° SUTURING IN 2 CASES, 
FASCIOTOMY IN 2 
EXTREMITY,  
ALL 7 CASES 
IMPROVED 
- 38 24 14 1 3 34 
DEBRIDEMENT IN 9 CASES, 
FASCIOTOMY IN 7 CASES, 
GRAFT IN 6 CASES, 
2° SUTURING IN 3 CASES, 
CONSERVATIVE IN 22 
CASES 
ALL 38 CASES 
IMPROVED 
 
INTERMDT 
RISK 
7 
+ 1 1 0 0 0 1 
DEBRIDEMENT AND 
GRAFT APPLIED 
IMPROVED 
- 6 4 2 0 0 6 
DEBRIDEMENT IN 3 CASES, 
FASCIOTOMY IN 3 CASES 
GRAFT IN 2 CASES , 
2° SUTURING IN 1 CASE 
IMPROVED 
 
HIGH RISK 8 
+ 6 4 2 0 0 6 
DEBRIDEMENT IN 6 CASES, 
GRAFT IN 2 CASES 
2 CASE 
IMPROVED, 
AMPUTATION 
IN 2 CASES, 
2 CASES DEAD 
- 2 2 0 0 0 2 
DEBRIDEMENT AND 
GRAFT IN 1 CASE 
1 CASE 
IMPROVED, 
1 CASE DEAD 
 
 
  
Sensitivity, Specificity, PPV and NPV betweenRisk and LRINEC 
  
 Yellow - Sensitivity 
 Blue -  Specificity 
 Red - PPV 
 Pink - NPV 
 
 
LRINEC scoring system has a better sensitivity and positive predictive 
value in identifying the onset of necrotizing fasciitis in soft tissue infections.  
Of all the comorbidities Diabetes Mellitus was the most frequent 
predisposing factor followed by chronic renal failure in both primary and 
secondary NF in this study group. 
Table. 6 Clinical outcome in patients with co-morbidities 
CO-
MORBIDITY 
NO. 
OF 
CASES 
R
IS
K
 C
A
T
E
G
O
R
Y
 
N
O
. 
O
F
 C
A
S
E
S
 
T
IS
S
U
E
 D
IA
G
N
O
S
IS
 
NO. 
OF 
CASES 
M F 
SITE 
OUTCOME 
S
C
R
O
T
U
M
 
P
E
R
IN
E
U
M
 
E
X
T
R
E
M
IT
Y
 
DIABETES 23 
L 12 
+ 
 
0 0 0 0 0 0 
 
ALL CASES 
IMPROVED 
 
- 12 6 6 0 2 10 
I 4 
+ 
 
0 0 0 0 0 0 
 
ALL CASES 
IMPROVED 
 
- 4 3 1 0 0 4 
H 7 
 
+ 
 
5 3 2 0 0 5 
 
2 CASES 
IMPROVED, 
AMPUTATION IN 
2 CASES, 
3 CASES DEAD 
 
- 2 2 0 0 0 2 
 
Scores 
>=6 <6 
Risk 
 
 
 
 
Inter/high 
 
 
15 0 
100 0 
100 0 
Low 
 
 
0 45 
0 100 
0 100 
  
CRF 6 
L 2 
+ 1 1 0 1 0 0 ALL CASES 
IMPROVED - 1 0 1 0 0 1 
I 1 
+ 1 1 0 0 0 1 
IMPROVED 
- 0 0 0 0 0 0 
H 3 
+ 2 1 1 0 0 2 
3 CASES DEAD 
- 1 1 0 0 0 1 
 
L - Low risk 
I - Intermediate risk 
H - High risk 
 
Comparing hospital stay among DM 
 
DM 
Hospital stay 
p-value 
n Min Median Max 
Absent 37 6 9 40 
0.37 
Present 23 6 10 30 
 
The Length of Hospital stay in those with Diabetic Mellitus was not 
statistically significant when compared to patients without DM. 
 
 
 
 
 
  
Table.7 Characteristics in patients with LRINEC score < 6 and patients 
with ≥ 6 
VARIABLES 
LRINEC < 6 
(n = 45) 
LRINEC > 6 
(n = 15) 
p VALUE 
AGE ,years (mean) 53.24 56.33 0.37 
MALE SEX 31 11 0.74 
NECROSIS 8 10 0.000 
CREPITUS 0 5 0.001 
VITALS UNSTABLE 1 8 0.000 
INJURY 11 2 0.366 
UNKNOWN ETIOLOGY 34 13 0.366 
DM 12 11 0.001 
CRF 2 4 0.013 
DM WITH CRF 1 3 0.305 
SHT 4 0 0.232 
PVD 0 1 0.081 
NO. OF 
DEBRIDEMENT(min/median/max) 
1/2/3 0/ 1/ 2 0.00 
TIME FOR SURGERY 
(min/median/max) 
1/ 2/ 28 0/ 1/24 0.26 
AMPUTATION 0 2 0.013 
MORTALITY 0 3 0.013 
HOSPITAL STAY ((min/median/max) 7/13/24 6/11/40 0.05 
 
(p- value calculated by using Fisher’s exact and Pearson chi square methods.) 
  
In the above table the p-value (0.745) suggests that there is no association 
between gender and the severity of risk. There is no statistically significant 
difference between the mean age between two groups of severity. The cut off of 
LRINEC ≥ 6 has better sensitivity and specificity in identifying the risk of the 
patient.  
The p-value (0.001) reveals that there is an association between Diabetes 
Mellitus and the severity of  risk. The proportion of high/intermediate risk is 
more in DM group(73.33) compared to the Non-DM group(26.66). The p-
value(0.08)  for the comparison of mean hospital days among the group of 
severity indicates that there is no difference between the mean of hospital stay. 
A multi variate comparison could not be done using death as an outcome since 
there were only three deaths occurred and hence a good value of predictor could 
not be obtained in this study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
______________________________________________________________________________________________________________________ 
 
  
 
 
 
Necrotizing soft tissue infections are often fatal, characterized by 
extensive necrosis of the fascia and subcutaneous tissues. It is perhaps the most 
severe form of soft tissue infection potentially limb and life threatening. Early 
diagnosis of necrotizing fasciitis is essential to advocate timely management for 
the better wellbeing of the patient.  
LRINEC - Laboratory Risk Indicator for Necrotizing Fasciitis score is 
based on routine laboratory investigations that are readily available, at most 
centres that can help distinguish Necrotizing Fasciitis from other soft tissue 
infections. 
LRINEC scoring system has a better positive predictive value in 
identifying the onset of necrotizing fasciitis and risk strategizing of the patients 
with severe soft tissue infections.  
There is a statistically significant association between Diabetic Mellitus 
and the severity of risk.  
The significance of LRINEC score in predicting the clinical outcome of 
the disease could not be outlined because of limited population included in this 
study. 
 Further studies are needed to determine whether additional interventions 
targeted to the high mortality risk group can lead to improved outcomes. 
  
 
Finally, Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) 
score can be used as an adjunct in the management of soft tissue infections 
especially in secondary care hospitals and may prevent delayed referral to 
tertiary centres where experienced surgeons,  infectious disease and hyperbaric 
specialists may guide immediate operative and ancillary management, thereby 
improving the clinical outcome of the patient.
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APPENDIX – I 
ABBREVIATIONS 
C.  - Clostridium 
CRF  - Chronic Renal Failure  
CRP  - C Reactive Protein 
CT  - Computed Tomography 
DM  - Diabetics Mellitus 
ED  - Emergency Department 
GIT  - Gastro Intestinal Tract 
GAS  - Group A Streptococci 
HBO  - Hyperbaric oxygen 
IV  - Intravenous 
LRINEC - Laboratory Risk Indicator for Necrotizing Fasciitis 
MRI  - Magnetic Resonance Imaging 
NF  - Necrotizing Fasciitis 
NSTI  - Necrotizing soft tissue infection 
PVD  - Peripheral Vascular Disease  
SHT  - Systemic Hypertension 
sp.  - Species  
USG  - Ultrasonogram 
  
APPENDIX – II 
CONSENT FORM 
It has been explained to me in my mother tongue and I completely 
understand my condition, its related complications and the treatment options 
available. I have been explained in detail regarding this study-   “LRINEC – 
An Objective Scoring System as a tool for early diagnosis of Necrotizing 
Fasciitis.”I hereby give my consent to participate in the above mentioned study. 
 
 
Date: 
Place: 
 
 
  
Signature of the relative      Signature of the patient 
with name:      with name: 
   
 
 
Signature of the witness 
with name: 
 
 
  
APPENDIX - III 
PROFORMA 
1) NAME     - 
2) AGE     - 
3) SEX     - 
4) IP NO.     - 
5) D.O.A     - 
6) D.O.P     - 
7) D.O.D     - 
8) CLINICAL FINDINGS 
a) SITE & EXTENT   - 
b) INFLAMMATION  - 
c) INDURATION   - 
d) NATURE OF DISCHARGE   
9) VITALS ON ADMISSION 
a) TEMP    - 
b) PULSE RATE   - 
c) BP     - 
d) RR     - 
  
10) CO-MORBID FACTORS 
a) RECENT H/O INJURY OR SURGERY 
b) SMOKING 
c) ALCOHOL 
d) IF ON STEROIDS 
e) IMMUNO SUPPRESSORS 
f) IV DRUG USE 
11) CO-MORBID DISEASES 
a) DIABETES 
b) MALIGNANCY 
c) CARDIAC DISEASE 
d) PVD 
e) HIV/AIDS 
12) INVESTIGATIONS 
a) TOTAL COUNT   - 
b) BLOOD SUGAR   - 
c) HB     - 
  
d) SR.CREATININE   - 
e) SR.SODIUM   - 
f) CRP     - 
g) LRINEC SCORE   - 
h) PUS C&S    - 
i) X-RAY LOCAL REGION - 
j) HIV / HBsAgSTATUS  - 
13) MANAGEMENT 
a) DEBRIDEMENT 
NO. OF DEBRIDEMENTS - 
FREQUENCY & TOTAL - 
b) AMPUTATIONS 
c) SKIN GRAFTING 
14) FINAL OUTCOME 
a) STATUS OF DISEASED PART 
b) MORBIDITY/MORTALITY 
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3 NANDHA KUMAR 46306 29 M LT.FA 1 0 0 S 1 0 0 0 0 0 1 23000 80 10 0.9 125 55 5 L 1 4 0 0 0 1 1 0 8 0
4 ANAND 51079 32 M SCROTUM 1 1 0 S 0 1 0 0 0 0 1 12400 88 6.4 1.5 131 66 4 L 1 1 1 1 0 1 1 0 10 0
5 MALLAR 49312 66 F LT.LEG 1 0 0 S 0 1 0 0 0 0 0 12800 138 11.4 0.5 138 60 1 L 0 0 0 0 0 1 0 0 8 0
6 SURESH 58755 49 M RT. LL 1 1 0 US 0 1 1 0 1 0 1 25100 218 7.4 3.8 123 160 12 H 2 8 1 1 1 0 0 0 10 1
7 SHANMUGAM 70869 70 M LT. LEG 1 0 0 S 0 1 0 0 0 0 1 14100 175 10 1.9 143 80 4 L 1 4 0 0 0 1 1 0 9 0
8 ESWARAN 52606 32 M RT. LL 1 1 0 S 1 0 0 1 0 0 1 11500 92 10 0.6 141 90 2 L 1 5 1 0 0 1 1 0 14 0
9 PALANISAMY 54027 78 M LT. LL 1 0 0 S 0 1 1 0 0 0 1 12600 260 12 1 137 40 2 L 0 0 0 0 0 1 0 0 9 0
10 JAMES WILLIAM 72534 70 M RT. LEG 1 0 0 S 0 1 1 1 0 0 1 5000 141 13 1.1 134 80 3 L 0 0 0 0 0 1 0 0 7 0
11 PALANIAMMAL 72380 50 F RT. FOOT 1 0 0 S 1 0 0 0 0 0 0 11800 90 12.6 1 130 30 3 L 1 3 0 0 0 1 0 0 6 0
12 MURUGAN 71391 48 M BOTH LEGS 1 1 0 US 0 1 0 0 1 0 1 14600 102 9.4 2.8 133 96 6 I 3 2 1 1 0 1 1 0 19 0
13 MANI 72266 53 F LT. FOOT 1 0 0 S 0 1 1 0 1 0 0 6200 109 13.2 2.8 139 30 3 L 1 4 0 0 0 1 0 0 6 0
14 MURUGESHWARI 72461 41 F LT. FOOT 1 0 0 S 0 1 1 0 0 0 0 7800 323 10 1.5 134 55 5 L 1 24 0 0 0 1 1 0 6 0
15 SUBRAMANI 66638 53 M RT. THIGH 1 1 0 US 1 0 0 0 0 0 1 13700 132 8.1 0.8 142 104 2 L 2 6 1 1 0 1 0 0 40 0
16 ARUL RAJ 70440 44 M SCROTUM 1 1 0 S 0 1 0 0 1 0 1 13600 74 8.3 2.3 137 86 4 L 2 7 1 1 0 1 0 0 20 0
17 SRI RAMULU 70568 70 M LT. FOOT 1 0 0 S 0 1 1 0 0 0 0 12600 161 12.3 0.9 136 30 1 L 0 0 0 0 0 1 0 0 7 0
18 MAHESH 37012 68 M RT.FOOT 1 0 0 S 0 1 0 0 0 0 0 11200 123 11.2 0.8 132 68 3 L 0 0 0 0 0 1 0 0 7 0
19 RANI AMMAL 43786 56 F RT. HAND 1 0 0 S 1 0 0 0 0 0 0 14100 106 9 1.1 128 54 4 L 1 6 0 0 0 1 0 0 8 0
20 MALLIKA 60241 60 F LT. FOOT 1 1 0 S 0 1 1 0 0 0 0 16100 226 8 1.2 134 90 4 L 2 7 0 0 0 1 0 0 10 0
21 RAJA 58210 55 M PERINEUM 1 1 0 S 0 1 1 0 0 0 1 13300 320 11.3 1.4 128 110 4 L 2 5 0 1 0 1 0 0 11 0
22 KUMARI 60414 67 F RT. LEG 1 0 0 S 0 1 0 0 0 0 0 9800 120 9.2 0.9 132 60 4 L 0 0 0 0 0 1 1 0 6 0
23 RANJITH 54302 37 M SCROTUM 1 0 0 S 0 1 0 0 0 0 1 12200 96 13 1.1 134 40 3 L 1 7 0 1 0 1 1 0 24 0
24 RAMANI 30421 55 M RT. FOOT 1 1 1 US 0 1 1 0 0 0 1 23100 210 7.6 2.3 126 145 8 H 2 2 1 1 1 0 0 1 23 0
25 MURUGESH 44729 67 M RT. LEG 1 0 0 S 0 1 0 0 0 0 0 7800 87 10 0.6 132 40 4 L 0 0 0 0 0 1 0 0 9 0
26 MAYILAL 70353 64 F RT. LEG 1 1 0 S 0 1 1 1 0 0 0 8800 146 9 1 132 50 4 L 0 0 0 0 0 1 0 0 9 0
27 NARAYANAN 45622 42 M RT. HAND 1 0 0 S 1 0 0 0 0 0 1 11100 88 12 0.8 135 60 3 L 1 6 0 0 0 1 0 0 7 0
28 KANDASAMY 53621 55 M LT. FOOT 1 0 0 S 0 1 0 0 0 0 0 8800 96 11.5 0.9 142 98 1 L 0 0 0 0 0 1 0 0 8 0
29 MAHENDRAN 40300 61 M RT. LEG 1 1 0 US 0 1 1 0 0 0 1 21000 132 8 2.2 128 140 7 I 2 4 0 1 0 1 1 0 7 0
30 KUMARAVELU 62111 56 M LT. FOOT 1 0 0 S 0 1 0 0 0 0 1 14400 124 11 1 134 90 3 L 0 0 0 0 0 1 0 0 11 0
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APPENDIX - V 
MASTER CHART 
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31 GOPALAKRISHNAN 67048 23 M LT. LEG 1 0 0 S 1 0 0 0 0 0 1 10400 129 11 1 132 100 3 L 1 7 0 1 0 1 0 0 8
32 RANGASAMY 72600 68 M LT. FOOT 1 0 0 S 0 1 1 0 0 0 1 10600 85 10.6 2.5 136 120 3 L 0 0 0 0 0 1 0 0 11
33 SAMYNATHAN 15137 78 M LT.  LL 1 0 0 S 1 0 1 0 1 0 0 20100 178 11.1 3.5 125 160 10 H 2 6 0 1 1 0 0 0 22
34 ABUTHAHEER 18229 48 M BOTH LEGS 1 0 0 S 0 1 0 0 0 0 0 8700 67 13.5 0.9 134 66 2 L 0 0 0 0 0 1 0 0 7
35 RAMALINGAM 35543 63 M RT. HAND 1 0 0 S 0 1 1 1 0 0 1 11000 327 9 0.9 127 100 5 L 1 6 0 0 1 1 0 0 30
36 MUTHUKUMAR 44253 34 M LT. HAND 1 0 0 S 1 0 0 0 0 0 1 9900 74 12 0.8 134 80 3 L 0 0 0 0 0 1 0 0 10
37 VELLACHI 65439 64 F RT.FOOT 1 1 0 S 0 1 0 0 0 0 0 17600 104 8 1.8 129 135 7 I 2 2 0 1 0 1 0 0 9
38 RAJESWARAN 54306 56 M SCROTUM 1 1 0 S 0 1 0 0 0 0 0 20100 110 9 1.5 130 120 5 L 2 7 1 1 0 1 0 0 22
39 RAVI SHANKAR 64021 54 M BOTH LEGS 1 0 0 US 0 1 0 0 0 0 1 26100 146 7.6 2 128 150 12 H 3 1 1 1 0 1 1 0 18
40 GOWRI AMMAL 34208 67 F RT. FOOT 1 0 0 S 0 1 0 0 0 0 0 8400 86 9 0.8 135 80 2 L 0 0 0 0 0 1 0 0 8
41 LAKSHMI 64902 54 F LT. HAND 1 0 0 S 1 0 0 0 0 0 0 10100 91 9 0.9 135 110 2 L 0 0 0 0 0 1 0 0 9
42 RANI 72100 48 F PERINEUM 1 0 0 S 0 1 1 0 0 0 0 14600 120 8 1 136 88 2 L 1 5 0 1 0 1 0 0 12
43 MURALI 38154 63 M RT. LEG 1 1 0 S 0 1 1 0 0 0 1 17300 340 10 1.6 130 120 7 I 2 3 0 1 0 1 0 0 13
44 VIJAYARAJ 63820 45 M LT. FOOT 1 0 0 S 0 1 0 0 0 0 0 7700 96 12 0.9 135 90 1 L 0 0 0 0 0 1 0 0 11
45 MAHARANI 45320 56 F RT. FOOT 1 0 0 S 0 1 0 0 0 0 0 6800 98 11 0.8 135 30 1 L 0 0 0 0 0 1 0 0 9
46 KIRAT RAJ 32981 54 M LT. LEG 1 0 0 S 1 0 0 0 0 0 1 13300 124 13 1 132 60 3 L 0 0 0 0 0 1 0 0 8
47 SIVA 64010 45 M BOTH LEGS 1 0 0 S 0 1 1 0 0 0 1 20100 220 10 1.7 128 120 8 I 2 3 0 1 0 1 0 0 7
48 SUNDARI 43010 54 F RT. HAND 1 0 0 S 1 0 1 0 0 0 0 11300 340 8 1.4 133 140 5 L 1 6 0 0 0 1 0 0 14
49 MAHESHWARAN 50201 60 M RT. FOOT 1 0 0 S 0 1 0 0 0 0 1 8800 140 12 1.4 136 120 1 L 0 0 0 0 0 1 0 0 12
50 SARASWATHY 32012 55 F RT. LL 1 1 1 US 1 0 1 0 0 0 0 27400 450 8 2.8 124 160 13 H 3 2 1 1 1 0 0 1 22
51 SIVARAM 53010 54 M LT. LEG 1 0 0 S 0 1 0 0 0 0 0 6600 86 12 0.7 136 30 1 L 0 0 0 0 0 1 0 0 11
52 KRISHNA 30102 43 M SCROTUM 1 0 0 S 0 1 0 0 0 0 1 13200 108 10 1.2 134 90 3 L 2 6 1 1 0 1 0 0 9
53 PRABHU 45201 37 M PERINEUM 1 0 0 S 0 1 0 0 0 0 1 12100 74 12 0.8 133 30 3 L 1 6 0 0 0 1 0 0 7
54 VIJAYA LAKSHMI 65301 60 F LT. FOOT 1 0 0 S 0 1 0 0 0 0 0 5400 102 12 0.9 136 40 1 L 0 0 0 0 0 1 0 0 10
55 JEYARANI 30265 64 F BOTH LEGS 1 1 1 US 0 1 1 0 1 0 0 24300 324 7 5.6 124 180 12 H 2 2 1 1 1 0 0 0 10
56 SUNIL 47209 40 M SCROTUM 1 0 0 S 0 1 0 0 0 0 0 12300 98 10 1.4 133 90 3 L 2 7 1 1 0 1 0 0 12
57 SUNDARA PANDIAN 42302 60 M RT. LEG 1 0 0 S 0 1 0 0 0 0 1 6000 78 11 0.6 135 30 1 L 0 0 0 0 0 1 0 0 15
58 MANIAN 53012 58 M LT. LL 1 1 1 US 0 1 1 0 0 0 1 28100 320 8 2.6 114 180 13 H 3 2 1 1 0 1 1 0 24
59 KUMARAVEL 72310 54 M RT. FOOT 1 0 0 S 0 1 0 0 0 0 1 18100 160 11 1.6 130 100 4 L 1 7 0 0 0 1 1 0 8
60 MURUGAVALLI 32540 64 F LT. LEG 1 0 0 S 0 1 1 0 0 0 0 21000 320 9 1.8 130 140 8 I 2 3 0 1 0 1 0 0 9
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APPENDIX - VI 
KEY WORDS TO MASTER CHART 
INFLAMMATION, NECROSIS, CREPITUS, INJURY, SPONTANEOUS, DM, 
CRF, SHT, PVD, SMOKING    
0 - ABSENT        
1 - PRESENT       
VITALS          
S - STABLE        
US - UNSTABLE      
RISK CATEGORY        
L - LOW RISK        
I - INTERMEDIATE RISK      
H - HIGH RISK        
TISSUE BIOPSY         
0 - NEGATIVE        
1 - POSITIVE FOR NF     
PUS C & S          
0 - GROWTH ABSENT      
1 - GROWTH PRESENT      
OUTCOME          
PROGRESSED 
0 - NO PROGRESSION      
1 - PROGRESSION       
  
REGRESSED 
0 - NO REGRESSION     
1 - REGRESSION      
SKIN GRAFT 
0 - NOT APPLIED       
1 - APPLIED        
AMPUTATION 
0 - NOT DONE       
1 - AMPUTATION DONE      
DIED 
0 - ALIVE        
1 - DEAD        
DM - DIABETES MELLITUS      
CRF - CHRONIC RENAL FAILURE     
SHT - SYSTEMIC HYPERTENSION    
PVD - PERIPHERAL VASCULAR DISEASE   
RBS - RANDOM BLOOD SUGAR     
HB - HEMOGLOBIN       
CRP - C - REACTIVE PROTEIN     
NF - NECROTIZING FASCIITIS    
MEAN DURATION OF SURGERY IN HOURS  
HOSPITAL STAY IN DAYS     
 
